Endocannabinoid signaling directs periimplantation events

AAPS Journal

Volumn 8, Issue 2, 2006, Pages

  Wang, Haibin ^a   Xie, Huirong ^a   Dey, Sudhansu K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cannabinoid endocannabinoid; Embryo development; Embryo oviductal transport; Implantation; Mouse

Indexed keywords

CANNABINOID RECEPTOR; ENDOCANNABINOID;

EMBRYO DEVELOPMENT; FEMALE FERTILITY; FIRST TRIMESTER PREGNANCY; HYDROLYSIS; KNOCKOUT MOUSE; NONHUMAN; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS; TISSUE DIFFERENTIATION; UTERUS;

ANIMALS; BLASTOCYST; EMBRYO IMPLANTATION; EMBRYONIC DEVELOPMENT; ENDOCANNABINOIDS; FEMALE; MICE; MICE, MUTANT STRAINS; OVIDUCTS; PREGNANCY; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 33745482953     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj080250     Document Type: Review

References (47)

1. Dey SK, Lim H, Das SK, et al. Molecular cues to implantation. Endocr Rev. 2004;25:341-373.
2. Paria BC, Reese J, Das SK, Dey SK. Deciphering the cross-talk of implantation: advances and challenges. Science. 2002;296:2185-2188.
3. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7:185-199.
4. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400-1408.
5. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-194.
6. Carson DD, Bagchi I, Dey SK, et al. Embryo implantation. Dev Biol. 2000;223:217-237.
7. Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114:744-754.
8. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-564.
9. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-65.
10. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946-1949.
11. Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995;215:89-97.
12. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 1997;388:773-778.
13. Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA. 1995;92:4332-4336.
14. Paria BC, Das SK, Dey SK. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA. 1995;92:9460-9464.
15. Paria BC, Song H, Wang X, et al. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem. 2001;276:20523-20528.
16. Wang H, Guo Y, Wang D, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004;10:1074-1080.
17. Yang ZM, Paria BC, Dey SK. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod. 1996;55:756-761.
18. Paria BC, Ma W, Andrenyak DM, et al. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod. 1998;58:1490-1495.
19. Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994;350:240-244.
20. Rinaldi-Carmona M, Barth F, Millan J, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther. 1998;284:644-650.
21. Sharov AA, Piao Y, Matoba R, et al. Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol. 2003;1:e74.
22. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA. 1999;96:5780-5785.
23. Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA. 1999;96:14136-14141.
24. Heilman RD, Reo RR, Hahn DW. Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertil Steril. 1976;27:426-430.
25. Howe GR, Black DL. Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. J Reprod Fertil. 1973;33:425-430.
26. Kennedy DR, Marshall JM. Effect of adrenergic nerve stimulation on the rabbit oviduct: correlation with norepinephrine content and turnover rate. Biol Reprod. 1977;16:200-211.
27. Paria BC, Lim H, Wang XN, Liehr J, Das SK, Dey SK. Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology. 1998;139:5235-5246.
28. Das SK, Wang XN, Paria BC, et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 1994;120:1071-1083.
29. Yoshinaga K, Adams CE. Delayed implantation in the spayed, progesterone treated adult mouse. J Reprod Fertil. 1966;12:593-595.
30. McLaren A. Blastocysts in the mouse uterus: the effect of ovariectomy, progesterone and oestrogen. J Endocrinol. 1971;50:515-526.
31. Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA. 1997;94:4188-4192.
32. Goo Y, Wang H, Okamoto Y, et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem. 2005;280:23429-23432.
33. Wang J, Paria BC, Dey SK, Armant DR. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod. 1999;60:839-844.
34. Liu WM, Duan EK, Cao YJ. Effects of anandamide on embryo implantation in the mouse. Life Sci. 2002;71:1623-1632.
35. Wang H, Matsumoto H, Guo Y, Paria BC, Roberts RL, Dey SK. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci USA. 2003;100:14914-14919.
36. Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372:686-691.
37. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem. 2004;279:5298-5305.
38. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996;384:83-87.
39. Maccarrone M, DeFelici M, Klinger FG, et al. Mouse blastocysts release a lipid which activates-anandamide hydrolase in intact uterus. Mol Hum Reprod. 2004;10:215-221.
40. Paria BC, Deutsch DD, Dey SK. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Reprod Dev. 1996;45:183-192.
41. Paria BC, Zhao X, Wang J, Das SK, Dey SK. Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol Reprod. 1999;60:1151-1157.
42. Piomelli D. THC: moderation during implantation. Nat Med. 2004;10:19-20.
43. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Aro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 2000;355:1326-1329.
44. Maccarrone M, Bisogno T, Valensise H, et al. Low fatty acid amide hydrolase and high amandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod. 2002;8:188-195.
45. Song H, Lim H, Paria BC, et al. Cytosolic phospholipase A2alpha is crucial for 'on-time' embryo implantation that directs subsequent development. Development. 2002;129:2879-2889.
46. Ye X, Hama K, Contos JJ, et al. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 2005;435:104-108.
47. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796-1799.